Skip to content
Dr Zarir F. Udwadia
  • Home
  • About
    • Achievements
    • Publications
    • Highlights
    • News & Updates
  • Gallery
  • Patient Information
    • Asthma
    • COPD/Emphysema
    • Bronchiectasis
    • Interstitial Lung Disease
    • Idiopathic Pulmonary Fibrosis
    • Sarcoidosis
    • Tuberculosis
    • Multi-drug resistant tuberculosis
    • Obstructive Sleep Apnea Syndrome
  • Contact
  • Corona Updates
Menu Close
  • Home
  • About
    • Achievements
    • Publications
    • Highlights
    • News & Updates
  • Gallery
  • Patient Information
    • Asthma
    • COPD/Emphysema
    • Bronchiectasis
    • Interstitial Lung Disease
    • Idiopathic Pulmonary Fibrosis
    • Sarcoidosis
    • Tuberculosis
    • Multi-drug resistant tuberculosis
    • Obstructive Sleep Apnea Syndrome
  • Contact
  • Corona Updates

Publication

  1. Home>
  2. Publication>
  3. Page 4
  • Post author:plus91
  • Post published:October 23, 2017
  • Post category:Publication
  • Post comments:0 Comments

AbstractWe report the experiences of 5 patients taking bedaquiline with delamanid in combination: 1 patient was cured; 3 culture converted, with 2 continuing and 1 changing therapy; and…

Continue ReadingBedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
  • Post author:plus91
  • Post published:August 17, 2017
  • Post category:Publication
  • Post comments:0 Comments

Go to Publication

Continue ReadingDenying access to bedaqualine in India costs lives.
  • Post author:plus91
  • Post published:May 21, 2017
  • Post category:Publication
  • Post comments:0 Comments

AbstractLarge studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and effectiveness of bedaquiline-containing regimens…

Continue ReadingEffectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.
  • Post author:plus91
  • Post published:March 24, 2017
  • Post category:Publication
  • Post comments:0 Comments

AbstractImatinib is a tyrosine kinase inhibitor and has rarely been reported to cause pleural effusion. We report the case of an 88-year-old male, known case of gastrointestinal stromal…

Continue ReadingImatinib-induced pleural effusion: A case report.
  • Post author:plus91
  • Post published:March 22, 2017
  • Post category:Publication
  • Post comments:0 Comments

Go to Publication

Continue ReadingCompassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India.
  • Post author:plus91
  • Post published:March 15, 2017
  • Post category:Publication
  • Post comments:0 Comments

Go to Publication

Continue ReadingInterstitial Lung Disease in India. Keep Searching and You’ll Keep Finding.
  • Post author:plus91
  • Post published:March 15, 2017
  • Post category:Publication
  • Post comments:0 Comments

AbstractGlobal tuberculosis incidence has declined marginally over the past decade, and tuberculosis remains out of control in several parts of the world including Africa and Asia. Although tuberculosis…

Continue ReadingThe epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.
  • Post author:plus91
  • Post published:February 19, 2017
  • Post category:Publication
  • Post comments:0 Comments

Go to Publication

Continue ReadingFailure to reach therapeutic levels of rifampicin and isoniazid by recommended dosages.
  • Post author:plus91
  • Post published:December 20, 2016
  • Post category:Publication
  • Post comments:0 Comments

AbstractSETTING:Tuberculosis (TB) hospital in Mumbai, India.OBJECTIVE:To describe the mobility patterns of persons with suspected drug-resistant tuberculosis (DR-TB) and to assess whether there were significant differences in demographic or…

Continue ReadingMobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India.
  • Post author:plus91
  • Post published:November 16, 2016
  • Post category:Publication
  • Post comments:0 Comments

Go to Publication

Continue ReadingTherapeutic choices in rifampicin-resistant tuberculosis.
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 17
  • Go to the next page

Hinduja Hospital,

Mahim, Mumbai – 400016

Appointment –
022 45108181, 022 67668181

Office – 022 24447353

Breach Candy Hospital,

B. Desai Road, Mumbai – 400026

Appointment – 5-8 pm
022 23667900
022 23667995

 

Thomas Cook Building,

DN Road, Mumbai – 400001

Appointment – After 6 pm
022 22046210
022 67439337

Copyright 2026 - Dr.Zarir Udwadia